Document is current
Any future updates will be listed below
-
Authors
Lebellec, Loïc
Bertucci, François
Tresch-Bruneel, Emmanuelle
Ray-Coquard, Isabelle
Le Cesne, Axel
Bompas, Emmanuelle
Blay, Jean-Yves
Italiano, Antoine
Mir, Olivier
Ryckewaert, Thomas
Toiron, Yves
Camoin, Luc
Goncalves, Anthony
Penel, Nicolas https://orcid.org/0000-0001-5243-1548
Le Deley, Marie-Cécile
-
Funding
Funding for this research was provided by:
Institut National Du Cancer (PHRC 2010)
Roche (0906-EPPA153667-G)
- License Information
-
More Information
Article History
Received: 26 April 2018
Accepted: 18 September 2018
First Online: 11 October 2018
Ethics approval and consent to participate
: Study investigations were conducted after approval by the local Ethics Committee (Nord-Ouest IV Commit de Protection des Patients) on 9th March, 2010, and after the approval of the French Health Authority (AFSSAPS) on 12th April, 2010. Signed informed consent was obtained from each patient. The study was registered in the European Clinical Trials Register (EudraCT N° 2009–017020-59) and in the US Clinical Trials Register (NCT01303497) and was conducted in agreement with the Declaration of Helsinki and International Conference on Harmonization of Good Clinical Practice guidelines.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
